Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Holmium Ho 166 DOTMP may deliver radiation directly to cancer
cells and cause less damage to normal tissue. Combining chemotherapy and holmium Ho 166 DOTMP
with peripheral stem cell transplantation may allow the doctor to give higher doses of
chemotherapy and holmium Ho 166 DOTMP and kill more tumor cells.
PURPOSE: Phase I/II trial to study the effectiveness of combining holmium Ho 166 DOTMP with
melphalan and peripheral stem cell transplantation in treating patients who have multiple
myeloma.